Cardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real-time streams of multiomics signals into digital information.
Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on our planet: Nature and biology. The Internet of Biology is that way becoming possible.
Cardea is headquartered in San Diego and has additional activity in Los Angeles. Cardea is a 100% American developed and built biocompatible semiconductor technology for applications across a variety of sectors including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health.
In May 2023, Cardea Bio became part of Paragraf, who has revolutionized graphene electronic device manufacturing with its pioneering scalable approach, making it the world's first company to achieve this feat. The acquisition of Cardea Bio and creation of Paragraf USA will enable Paragraf to offer a new generation of biosensing devices that will deliver the features and result sensitivity of existing lab-based instruments, with the rapid response and simple ease of use required to enable handheld, real-time, in the field use.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 8969 Kenamar Dr.,
- Phone
- (+1) 619 762 1142
- in****@****bio.com
- Industry
- Semiconductor Manufacturing
- NAICS
-
Semiconductor and Other Electronic Component Manufacturing
- Website
- cardeabio.com
- Keywords
- Digital Biology, Biology, CRISPR, BPU, multiomics, Biosignal Processing Unit, Internet of Biology.
- HQ
- San Diego, California
Cardea Bio (Part Of Paragraf®) Questions
Cardea Bio (Part Of Paragraf®)'s helpline number is (+1) 619 762 1142
Cardea Bio (Part Of Paragraf®)'s website is cardeabio.com
Cardea Bio (Part Of Paragraf®)'s LinkedIn profile is https://www.linkedin.com/company/cardeabio
Cardea Bio (Part Of Paragraf®) has
8 employees.
View email and phone details for 8
employees at Cardea Bio (Part Of Paragraf®).
Cardea Bio (Part Of Paragraf®)'s industry is
Semiconductor Manufacturing
Cardea Bio (Part Of Paragraf®)'s top competitors are
Paragraf,
Exozymes (Nasdaq: Exoz),
Aran Lab,
Iqe,
Porotech,
Crispr Qc,
Pragmatic Semiconductor,
Agile Analog,
Cambridge Gan Devices Ltd,
Aran Nebula.
Cardea Bio (Part Of Paragraf®)'s support email address is info@cardeabio.com
Cardea Bio (Part Of Paragraf®)'s categories are Semiconductor Manufacturing
Cardea Bio (Part Of Paragraf®)'s founding year is 2019
